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Mutations in PINK1 cause autosomal recessive
Parkinson’s disease. PINK1 is a mitochondrial kinase
of unknown function. We investigated calcium
homeostasis and mitochondrial function in PINK1-
deficient mammalian neurons. We demonstrate phys-
iologically that PINK1 regulates calcium efflux from
the mitochondria via the mitochondrial Na+/Ca2+
exchanger. PINK1 deficiency causes mitochondrial
accumulation of calcium, resulting in mitochondrial
calcium overload. We show that calcium overload
stimulates reactive oxygen species (ROS) production
via NADPH oxidase. ROS production inhibits the
glucose transporter, reducing substrate delivery and
causing impaired respiration. We demonstrate that
impaired respiration may be restored by provision of
mitochondrial complex I and II substrates. Taken
together, reduced mitochondrial calcium capacity
and increased ROS lower the threshold of opening
of the mitochondrial permeability transition pore
(mPTP) such that physiological calcium stimuli
become sufficient to induce mPTP opening in
PINK1-deficient cells. Our findings propose a mecha-
nism by which PINK1 dysfunction renders neurons
vulnerable to cell death.
INTRODUCTION
Mitochondrial dysfunction has been implicated in a range of
neurodegenerative diseases, in particular, Parkinson’s disease
(PD). PD is a common neurodegenerative disease characterized
initially by loss of dopaminergic neurons in the substantia nigra
(SN), and later, by more widespread nondopaminergic neuronal
loss (Braak et al., 2003). The molecular pathogenesis of sporadicMPD, and the basis for selective dopaminergic neuronal loss,
remains unclear. Several genes have now been identified in
which mutations cause forms of familial PD that are clinically
and pathologically indistinguishable from sporadic PD. A
number of these genes, namely PINK1, DJ-I, and Omi/HtrA2,
encode mitochondrially located proteins, further implicating
mitochondrial dysfunction as the primary event sufficient to
cause PD.
Mutations in the PINK1 gene cause autosomal recessive PD
(Valente et al., 2004). PINK1 is a 581 amino acid protein consist-
ing of a mitochondrial targeting motif and a serine/threonine
kinase domain homologous to the Ca2+/calmodulin family.
Studies both in vitro (Silvestri et al., 2005; Muqit et al., 2006)
and in vivo (Gandhi et al., 2006) show PINK1 localized to
mitochondria. The targets for PINK1 remain unknown, although
mitochondrial proteins such as Omi/HtrA2 (Plun-Favreau et al.,
2007) and TRAP1 (Pridgeon et al., 2007) have been identified
as downstream effectors of PINK1 function. It is well established
that PINK1 protects neurons from oxidative stress, and further-
more plays a role in mitochondrial morphology in mammalian
cells and Drosophila models (Haque et al., 2008; Exner et al.,
2007; Yang et al., 2006).
We previously demonstrated that PINK1 deficiency results in
an age-related loss of neuronal viability, and increased sensitivity
to stress-induced mitochondrial apoptosis. In keeping with other
reports, mitochondrial dysfunction was implicated due to the
presence of lowered mitochondrial membrane potential,
increased oxidative stress, and morphological changes of
mitochondria associated with PINK1 deficiency (Wood-Kaczmar
et al., 2008). However, the mechanisms underlying the mito-
chondrial membrane potential, the sources of oxidative stress,
and basis of the sensitivity to apoptosis remained unknown. In
this study we used dynamic imaging techniques to explore
the mitochondrial pathophysiology of PINK1-induced PD. We
report that loss of PINK1 function causes dysregulation of mito-
chondrial calcium handling, resulting in mitochondrial calcium
overload which sensitizes the mitochondria to opening of the
permeability transition pore (PTP). Furthermore, we explain theolecular Cell 33, 627–638, March 13, 2009 ª2009 Elsevier Inc. 627
Molecular Cell
PINK1 Deficiency and Mitochondrial FunctionFigure 1. Characteristics of Mitochondrial Membrane Potential in PINK1 KD Neurons
(A) Immunofluorescence of human dopaminergic neurons (Ai) (blue, Hoechst; red, b3 tubulin; green, TH) and primary mouse neurons (Aii) (blue, Hoechst; red,
GFAP; green, MAP). Scale bar, 10 mM.
(B) PINK1 KD neuroblastoma cells showed a 43% reduction (n > 120, p < 0.0001) in basal mitochondrial membrane potential (Dcm) compared to control cells (Bi).
PINK1 KD human neurons exhibited 16% reduction (n > 60, p < 0.005) in basal Dcm compared to controls (Bii).
(C) In WT mouse neurons (Ci), oligomycin did not affect Dcm; rotenone induced partial depolarization; FCCP induced complete depolarization. In PINK1 KO
mouse neurons (Cii), oligomycin induced mitochondrial depolarization (78.6% ± 4.8% decrease in Dcm, n = 72).
(D) Application of methyl succinate to PINK1 KO mouse neurons increased basal Dcm (19.5% ± 2.1%); application of pyruvate or malate to PINK1 KO neurons
also increased the basal Dcm (18.6% ± 0.7%, n = 87). Substrate provision abolished oligomycin-induced mitochondrial depolarization in PINK1 KO.
Error bars represent mean ± SEM.basis for the impaired respiration and oxidative stress in PINK1
models of PD. These findings define a mechanism whereby
PINK1 dysfunction may cause nigral neuronal death, and high-
light pathophysiological processes that may also occur in
sporadic PD.
RESULTS
Using stable expression of shRNA constructs, we were able
to reduce PINK1 gene expression by >90% in (1) a human
dopaminergic neuroblastoma cell line (SH-SY5Y), and (2) human
neurons derived from fetal mesencephalic stem cells that
represent the closest in vitro model of primary human neurons.
Finally, we corroborated our findings with another mammalian
model: (3) primary cortical and midbrain neurons from a PINK1
knockout (KO) transgenic mouse (Figures 1Ai and 1Aii). The
characterization of these models has been extensively described
(Wood-Kaczmar et al., 2008). Stable re-expression of wild-type
(WT)-PINK1 or the kinase-dead mutant K219M-PINK1 was
achieved in PINK1 knockdown (KD) neuroblastoma cells and
confirmed by RT-PCR.628 Molecular Cell 33, 627–638, March 13, 2009 ª2009 Elsevier IncMitochondrial Membrane Potential
Mitochondrial membrane potential (Dcm) is an indicator of
mitochondrial state. To control for the effect of multidrug resis-
tance pumps on loading of dyes and experimental results, cells
were initially loaded in the presence of the MDR inhibitor cyclo-
sporine H. No difference in loading or in results was detected,
and therefore all further experiments were conducted without
cyclosporine H.
PINK1 KD in neuroblastoma cells is associated with a signifi-
cant reduction in the TMRM signal by 43% compared to controls
(n > 120 cells in >2 clones, p < 0.0001). Re-expression of WT
PINK1, but not K219M-PINK1, rescued the TMRM signal in
neuroblastoma cells (data not shown). PINK1 KD in human
neurons is also associated with a significant lowering of the
mean TMRM fluorescence signal by 16% (n = 60 in two clones,
p < 0.005) (Figures 1Bi and 1Bii). These data suggest that PINK1
KD is associated with lowering of the basal Dcm. As basal
accumulation of TMRM may be dependent on several factors
including plasma membrane potential, we investigated the
mechanism maintaining the Dcm by studying the sensitivity of
Dcm to a range of mitochondrial inhibitors..
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polarization in response to complex V inhibition by oligomycin
(0.2 mg/ml), while subsequent inhibition of complex 1 by rotenone
(5 mM) caused a rapid loss of potential (Figure 1Ci). Therefore, in
control neurons, theDcm is maintained by the activity of the respi-
ratory chain, with contributions from both complex I and complex
II (100% = basal Dcm, 0 = FCCP Dcm at end). In contrast,
oligomycin caused marked mitochondrial depolarization in
PINK1 KD/KO neurons (78.6% ± 4.8% decrease in TMRM signal
in mouse KO cortical neurons, n = 72 cells; 84.6% ± 3.2% for
human KD neurons, n = 112 cells; Figure 1Cii). Therefore, in
PINK1 KD/KO cells, Dcm is largely maintained by the hydrolysis
of ATP by complex V, rather than by respiration.
Provision of additional substrate for complex 1 (5 mM pyruvate
and 5 mM malate) to PINK1 KD neurons caused an increase in
Dcm (TMRM signal increased by 23.4% ± 1.9%, n = 68 for human
neurons and by 18.6% ± 0.7%, n = 87 for mouse KO neurons).
The membrane-permeable succinate analog (5 mM methyl
succinate) also increased basal Dcm in PINK1 KO neurons (by
19.5% ± 2.1%; Figure 1D). Importantly, the provision of complex
I and II substrates to PINK1 KD/KO neurons completely
prevented the oligomycin-induced depolarization (Figure 1D).
Thus, respiration is insufficient to maintain the Dcm in PINK1
KD/KO cells, although the normal mechanisms that maintain
Dcm may be restored in PINK1 KD neurons by increasing
substrate supply to complex I and II.
Respiratory Function
Redox State
The redox state of NADH or FAD2+ is a function of respiratory
chain activity and the rate of substrate supply. We measured
the resting level of NADH and FAD2+ autofluorescence and
generated the ‘‘redox index,’’ a ratio of the maximally oxidized
(response to 1 mM FCCP) and maximally reduced (response to
1 mM NaCN) signals. The redox index of NADH in the PINK1
KD cells was significantly more oxidized than in controls
(PINK1 KD neurons, 54.9% ± 3.3%, n = 69, compared to control
neurons, 25.2% ± 1.9%, n = 65; PINK1 KD neuroblastoma,
65.7% ± 4.1%, n = 41, compared to control neuroblastoma cells,
29.6% ± 2.3%, n = 39; PINK1 KO mouse neurons, 53.6% ± 4.7%
(n = 99), compared to control mouse neurons, 23.4% ± 1.8%,
n = 86; p < 0.001 for all type of the cells) (Figure 2). Re-expression
of WT, but not kinase mutant PINK1, restored the basal NADH
redox level in PINK1 KD neuroblastoma cells to values equivalent
to the controls (59.7% ± 5.1%). In addition, FAD2+ level was
more oxidized in PINK1 KD neuroblastoma cells (PINK1 KD,
49.7% ± 4.3%, compared to control, 37.5% ± 2.9%, p < 0.05;
Figures 2A, 2B, and 2D). Re-expression of WT PINK1 recovered
FAD2+ to control levels (Figure 2D).
The more oxidized redox level in PINK1 KD/KO cells may be
due to a rate-limiting substrate supply (Duchen et al., 2003).
Preincubation (for 20 min) of PINK1 KO neurons with 5 mM
pyruvate restored the redox state to control values (a rise from
23.4% ± 1.8% to 54.8% ± 4.9%; n = 71; p < 0.001) (Figure 2E).
In contrast, inhibition of glycolysis by iodoacetic acid (IAA,
10 mM) in WT mouse neurons decreased the redox level to values
comparable PINK1 KO neurons (from 53.6% ± 4.7% to 26.1% ±
2.1%; n = 59; p < 0.001) (Figure 2F).MOxygen Consumption. The basal oxygen consumption
(Figure 2G) was significantly reduced in the PINK1 KD cells
(0.41 ± 0.033 nmol/O2/min/10
6 cells; n = 4 experiments)
compared to control cells (0.79 ± 0.101 nmol O2/min/10
6;
n = 4 experiments; p < 0.05). Oligomycin 2 mg/ml inhibited the
respiration coupled to oxidative phosphorylation in control cells
(to 0.33 ± 0.025 nmol O2/min/10
6, p < 0.05), but not in PINK1 KD
cells (0.38 ± 0.022 nmol O2/min/10
6 compared to basal 0.41 ±
0.033 nmol/O2/min/10
6). FCCP (1 mM) accelerated respiration
to maximal levels in control cells, but to a lesser extent in
PINK1 KD cells (3.98 ± 0.19 versus 1.14 ± 0.089 nmol/O2/min/
106). These data suggest a generalized impairment of respiration
in PINK1 KD cells.
Application of 5 mM pyruvate to PINK1 KD neuroblastoma
cells resulted in an increase in basal respiration to control values
(from 0.41 ± 0.033 nmol/O2/min/10
6 cells to 0.81 ± 0.09 nmol/
O2/min/10
6 cells; n = 4 experiments; p < 0.001). Of note, the
presence of pyruvate also changed the response of the cells to
oligomycin. Maximal respiration induced by FCCP was also
significantly higher following addition of pyruvate in PINK1 KD
cells (3.89 ± 0.15 versus 1.14 ± 0.089 nmol/O2/min/10
6;
p < 0.001; n = 4 experiments). Application of methyl succinate
significantly stimulated cell respiration increasing the maximal
rate of respiration (basal rate increased to 0.63 ± 0.07 nmol/
O2/min/10
6; FCCP-induced respiration increased to 3.37 ±
0.17 nmol/O2/min/10
6; n = 4 experiments; p < 0.001;
Figure 2G). Therefore the respiratory chain is intact in PINK1
KD cells and the inhibition of respiration in these cells is due
the lack of substrates for complex I.
Glucose Uptake. To investigate the availability of substrates
for the respiratory chain complexes, we studied the uptake of
fluorescent glucose (2-NBDG 2 mM in medium containing low
glucose [2 mM]). The rate of glucose uptake in mouse PINK1
KO neurons (cortical and midbrain; n = 114) was significantly
slower compared to WT (n = 122) neurons (41.7% ± 3.9% of
control; p < 0.001; see Figure S1A available online). In human
PINK1 KD neurons, the rate of glucose uptake was 54.1% ±
5.1% of control (n = 58 for control; n = 63 for KD) In PINK1 KD
neuroblastoma cells, the rate of glucose uptake was 63.8% ±
5.4% of control cells (n = 112 for control; n = 94 for KD;
p < 0.001) (Figure S1B).
PINK1 deficiency is associated with reduced glucose uptake,
resulting in a global impairment of respiration. Thus provision
of respiratory chain substrates is able to reverse the impaired
respiration, the altered redox state and the lowered Dcm.
Calcium Homeostasis
Effect of Physiological and UV-Induced Calcium Stimuli
Mitochondria play a major role in maintaining neuronal calcium
homeostasis (Szabadkai et al., 2006). In order to examine mito-
chondrial calcium handling in the PINK1 KD/KO cells, we
measured fura-2 and Rh123 fluorescence (dequench mode)
simultaneously as indicators of [Ca2+]c and Dcm. Application
of 50 mM KCl depolarizes the plasma membrane in neurons,
induces the opening of potential-sensitive calcium channels,
causing a rise in [Ca2+]c. Application of 50 mM KCl to WT mouse
neurons produced a [Ca2+]c signal, with no significant mito-
chondrial depolarization as characterized before (Keelan et al.,olecular Cell 33, 627–638, March 13, 2009 ª2009 Elsevier Inc. 629
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neurons induced a much higher [Ca2+]c signal (signal increase:
control 0.52 ± 0.001, n = 134, compared to 1.12 ± 0.1 in
PINK1 KD, n = 187; p < 0.001; Figure 3Aii), which was associ-
ated with a major loss of Dcm (the Rh123 signal rose by
68.9% ± 5.7%, n = 187) (Figure 3Aii). In human neurons, KCl
induced a small rise in the [Ca2+]c in control neurons (Figure 3Bi)
and a much higher [Ca2+]c in PINK1 KD neurons (0.36 ± 0.1,
n = 133 in control compared to 0.76 ± 0.41, n = 102;
Figure 3Bii). The higher [Ca2+]c in PINK1 KD neurons was asso-
ciated with profound lowering of Dcm (Rh123 signal increased
by 94% ± 6.6%). The mitochondrial depolarization was pre-
Figure 2. Redox State and Rate of Oxygen Consump-
tion in PINK1 KD/KO and Control Cells
(A and B) Graphs demonstrate averaged trace of NADH and
FAD2+ autofluorescence in neuroblastoma cells ([A], control;
[B], PINK1 KD). The response to FCCP (1 mM) is larger in the
control cells; the response to cyanide (1 mM) is larger in
PINK1 KD cells.
(C and D) Quantification of the percentage change in NADH or
FAD2+ fluorescence: 0 is response to FCCP, and 100% is
response to cyanide; this is reversed for FAD fluorescence.
PINK1 KD/KO neurons have lower NADH fluorescence
compared to control neurons. PINK1 KD neuroblastoma cells
have lowered NADH fluorescence and increased FAD2+ fluo-
rescence than controls. This can be reversed by re-expression
of WT PINK1 in PINK1 KD cells.
(E) Preincubation of PINK1 KO mouse neurons with 5 mM
pyruvate restored redox level to control values.
(F) Preincubation of WT mouse neurons with IAA to inhibit
glycolysis reduced redox level to PINK1 KD values.
(G) The basal rate of oxygen consumption is reduced in PINK1
KD neuroblastoma cells compared to control cells. PINK1 KD
cells show no response to oligomycin. The maximal rate of
respiration and oxygen consumption induced by FCCP was
significantly lower in PINK1 KD cells than control cells.
Pyruvate 5 mM and methyl succinate increased basal
oxygen consumption, and increased FCCP induced maximal
respiration.
Error bars represent mean ± SEM.
vented by preincubation with the mPTP inhibitor
cyclosporin A (CsA) (0.5 mM; Figure 3C).
Neuroblastoma cells were loaded with fluo-4 and
TMRM (redistribution mode) for simultaneous
measurement of [Ca2+]c and Dcm. Application of
100 mM ATP to neuroblastoma cells induced
a [Ca2+]c signal in both control (n = 61; Figure 3D)
and PINK1 KD cells (n = 56; Figure 3E). The
[Ca2+]c signal in the PINK1 KD cells was again signif-
icantly larger than in control cells and again induced
a mitochondrial depolarization (TMRM signal
decreased by 65.7 ± 5.8%, n = 56). Calcium-
induced depolarization in PINK1 KD neuroblastoma
cells was prevented by preincubation of cells with
0.5 mM CsA (n = 48; data not shown).
We employed the technique of UV flash photol-
ysis of cells incubated with caged calcium (Ca-
NPEGTA) in order to generate a standard calcium
signal free from variations in calcium influx/release.
UV induced flash photolysis produced a rapid [Ca2+]c increase in
WT mouse cortical neurons with no associated change in Dcm
(n = 46; Figure 4A). Conversely, the same stimulus in PINK1
KO mouse neurons resulted in profound mitochondrial depolar-
ization (n = 38; Figure 4B). Similarly control human neurons
showed a rise in [Ca2+]c with no mitochondrial depolarization
(n = 35; data not shown), whereas PINK1 KD neurons exhibited
a rise in [Ca2+]c, followed by a stepwise mitochondrial depolar-
ization, where each step coincided with each UV induced
[Ca2+]c rise (n = 38; Figure 4C). Interestingly, following recovery
of the [Ca2+]c signal, fluo-4 showed a very bright signal colocal-
izing completely with the TMRM signal, reflecting high levels of630 Molecular Cell 33, 627–638, March 13, 2009 ª2009 Elsevier Inc.
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a calcium signal in these cells caused a profound mitochondrial
depolarization and disappearance of the mitochondrially located
TMRM signal. Application of FCCP to control neurons caused
complete depolarization of the mitochondria. Application of
FCCP in PINK1 KD neurons did not produce any further depolar-
ization. Mitochondrial depolarization was prevented by applica-
tion of CsA. Provision of respiratory chain substrates (5 mM
pyruvate and methyl succinate) did not prevent calcium-induced
mitochondrial depolarization in PINK1 KO cells.
The sustained increase in [Ca2+]m suggested a possible
impairment of calcium efflux from the mitochondria, mediated
by the Na+/Ca2+ exchanger. Preincubation of control neurons
with a specific inhibitor of the Na+/Ca2+ exchanger, 10 mM
CGP-37157, converted the signal in control neurons to one iden-
tical to PINK1 KD neurons mimicking the [Ca2+]m overload and
inducing mitochondrial depolarization (n = 31; Figure 4D).
In PINK1-deficient cells, physiological [Ca2+]c stimuli induce
[Ca2+]m overload, opening of the PTP, and mitochondrial depo-
larization.
Figure 3. Physiological Calcium Stimuli Induce
Mitochondrial Depolarization in PINK1 KD Cells
(A–C) Mouse (Ai and Aii) and human (Bi–Biii) neurons were
loaded with fura-2 am and Rh123. KCl (50 mM) produced
a rise in [Ca2+]c in mouse wild-type neurons (Ai) and human
control neurons (Bi). In PINK1 KO mouse neurons (Aii) and in
PINK1 KD human neurons (Bii), the [Ca2+]c was associated
with an increase in Rh123 fluorescence and Dcm depolariza-
tion. Preincubation of human PINK1 KD neurons with 0.5 mM
CsA prevented the Dcm depolarization of cells, but not the
[Ca2+]c signal (C).
(D and E) Human neuroblastoma cells were loaded with fluo-4
(green) and TMRM (red). ATP (100 mM) induced a rise in [Ca2+]c
and thus an increase in fluo-4 fluorescence. In PINK1 KD cells
the ATP-induced [Ca2+]c signal was associated with
a decrease in TMRM fluorescence and Dcm depolarization.
Error bars represent mean ± SEM.
Mitochondrial Calcium Transport. Cells were
loaded with Ca-NPEGTA, Sodium Green and
Rhod-5n (concentrates in mitochondria), and per-
meabilized in pseudo-intracellular solution contain-
ing 20 mM digitonin (Abramov et al., 2007). In these
conditions, a significant fraction of the caged Ca2+
is entrapped within mitochondria, enabling selec-
tive photolysis-induced release of Ca2+ inside the
mitochondrial matrix (independent of mitochondrial
uptake and Dcm). As the cells are permeabilized,
this protocol excludes any difference in intracellular
Na+ concentration or pH as the basis for altered
mitochondrial Ca2+ handling. In control neurons,
flash photolysis induced a rise in [Ca2+]m, with
a concomitant reduction in the [Na+ ]m. As demon-
strated in Figure 5A, each UV-induced Ca2+ peak is
followed by Ca2+ recovery coinciding with Na+
increase, reflecting the activity of the Na+/Ca2+
exchanger (antiporter). In PINK1 KD neurons each
UV-induced Ca2+ rise induced a stepwise increase
in [Ca2+]m without recovery (n = 58), associated with reduced Na
+
influx compared to control cells (Figure 5B). We were able to
inhibit the Na+/Ca2+ exchanger in control neurons by application
of 10 mM CGP-37157 (n = 45 cells; Figure 5C), or by using
medium without Na+ (n = 63; Figure 5D). In control neurons the
Na+/Ca2+ exchanger could be activated by addition of high
(50 mM) Na+ to the medium in the presence of 7 mM ruthenium
red (inhibitor of Ca2+ uniporter), inducing Ca2+ efflux from the
mitochondria (n = 61; Figure 5E). In PINK1 KD neurons, addition
of 50 mM Na+ to the medium induced a significantly smaller
effect on the [Na+]m rise with minimal Ca
2+ efflux (n = 53 cells;
Figure 5F). This data confirms that the Na+/Ca2+ exchanger is
dysfunctional in PINK1 KD neurons.
Mitochondrial Calcium Capacity. Permeabilized cells, loaded
withTMRMand fluo-4, were exposed to increasing concentrations
ofexogenousCa2+. Mitochondriaarebathed inmedium containing
pyruvate and malate so the basal Dcm is similar in all cells. We
defined Ca2+ capacity as the maximum Ca2+ concentration toler-
ated prior to the collapse of Dcm and the rapid disappearance of
fluo-4 signal from mitochondria (Murphy et al., 1996; Abramov
Molecular Cell 33, 627–638, March 13, 2009 ª2009 Elsevier Inc. 631
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models, we found that the mitochondrial Ca2+ uptake capacity of
control neurons was dramatically greater than PINK1 KO/KD
neurons. The threshold for mPTP opening in WT mouse neurons
was 325 mM, n = 25 cells (Figure 5I); for PINK1 KO cells the
threshold was only 20 mM, n = 19 (Figure 5J). The calcium capacity
could be restored to control values by preincubation of neurons
with CsA (0.5 mM) (PINK1 KO mouse neurons, capacity rose from
20 mM to 800 mM, n = 22, data not shown). For control human
neurons the threshold was 12.3 mM, n = 22 cells (Figure 5G)
compared to 225 mM for PINK1 KD neurons, n = 27 (Figure 5H).
Basal [Ca2+]m. Impaired mitochondrial calcium efflux should
result in a higher basal [Ca2+]m. PINK1 KD cells appeared to
Figure 4. A Rise in [Ca2+]c Induces [Ca
2+]m Overload
and Dcm Depolarization in PINK1 KD/KO Cells
(A) Arrows mark UV-induced flash photolysis of cells loaded
with Ca-NPEGTA, fluo-4, and TMRM. In (A), mouse WT
neurons demonstrated an increase in [Ca2+]c in response to
flash photolysis, with no change in Dcm.
(B) In mouse PINK1 KO neurons, flash photolysis induced an
increase in [Ca2+]c with profound depolarization of the mito-
chondria.
(C) In the same experiment performed on human PINK1 KD
neurons, the photolysis-induced rise in [Ca2+]c resulted in
a dramatic increase in [Ca2+]m, as demonstrated by the fluo-
4 signal in the mitochondrial area (Figure 4Cg). This was
rapidly followed by mitochondrial depolarization and subse-
quent release of fluo-4 from the mitochondrial area.
(D) Application of 10 mm CGP-37157 to control neurons
induced the same [Ca2+]m overload and Dcm depolarization
seen in PINK1 KD.
have 1.5-fold higher levels of mitochondrial-located
Rhod-5N fluorescence (Figures S2Ai and S2Aii)
although this is not a ratiometric dye and so cannot
be quantitated. We employed an indirect method to
measure basal [Ca2+]m: cells were first treated with
an inhibitor of ER calcium ATPase (1 mM thapsigar-
gin) to deplete Ca2+ from the ER in Ca2+free medium.
Application of ionomycin eliminates any remaining
[Ca2+] gradient between all membranes. Following
thapsigargin, the sole remaining gradient is the mito-
chondria-cytosolic [Ca2+] gradient which may be
quantified by measurements of releasable Ca2+
(Abramov and Duchen, 2003) The response to iono-
mycin i.e., the [Ca2+]m in PINK1 KO mouse neurons
and astrocytes was much higher than in control cells
(PINK1 KO neurons 196.5 ± 14.5% (n = 69) of WT
neurons (n = 88); p < 0.05; PINK1 KO astrocytes
148.6 ± 11.2% (n = 88) of control neurons (n = 74),
p < 0.05; Figures S2Bi, S2Bii, and S1C). [Ca2+]m was
also higher in PINK1 KD human neurons compared
to control neurons (PINK1 KD 183.7 ± 11.4%
(n = 67) of control (n = 45), p < 0.001; Figure S2D).
Oxidative Stress
Cytosolic ROS
We investigated ROS production in the cytosol and
in the mitochondrial matrix by measuring the rate of
oxidation of cytosolic hydroethidine (HEt) or the mitochondrially
targeted equivalent MitoSOX. The basal cytosolic ROS (cROS)
production in PINK1 KO mouse neurons was significantly higher
than in WT neurons (PINK1 KO 319.4% ± 11.3% of control,
n = 215, p < 0.001; Figures 6Ai and 6Aii). Stimulation of the cells
with 50 mM KCl produced a [Ca2+]c signal (as shown before) and
also stimulated ROS production in control cells (the rate of
increase of the HEt fluorescence rose to 351% ± 19.3%,
n = 199, p < 0.001). In PINK1 KD/KO cells 50 mM KCl showed
a small nonsignificant activation of ROS production (the rate
increased from 319.4% ± 11.3% to 330.1% ± 14.7%, n = 215).
Both the basal overproduction of ROS, as well as the KCl-stim-
ulated ROS production, was blocked by the NADPH oxidase
632 Molecular Cell 33, 627–638, March 13, 2009 ª2009 Elsevier Inc.
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KD/KO Neurons
(A–D) Flash photolysis of permeabilized neurons loaded with Sodium Green
and Rhod-5n demonstrated a flash-induced increase in [Ca2+]m followed by
Ca2+ efflux and Na+ influx in control cells (A). In PINK1 KD cells (B), there
was no recovery of the [Ca2+]m signal and reduced influx of Na
+. Application
of CGP-37157 (10 mM) to control neurons (C) inhibited the Na+/Ca2+
exchanger. Removal of Na+ from the medium in control neurons (D) also
inhibited the Na+/Ca2+ exchanger.
(E and F) Application of 50 mM NaCl in the presence of 7 mM ruthenium red
stimulated an increase in Na+ and decrease in Ca2+ in control mitochondria
(E). In contrast, there was minor activation of Na+/Ca2+ exchange in PINK1
KD mitochondria (F).
(G–J) Increasing concentrations of Ca2+ were applied to permeabilized human
neurons (G and H) or mouse neurons (I and J). Arrows indicate the final freeM(NOX) inhibitors DPI (0.5 mM) or AEBCF (20 mM; the basal rate
of HEt fluorescence was reduced from 319.4% ± 11.3% to
126.6% ± 10.32%, n = 111, p < 0.001 in DPI-treated cells,
Figure 6B). This suggests that cROS production in PINK1
deficiency is due to the basal and Ca2+-induced activation of
NOX.
To confirm the role of NOX in the production of ROS, we
performed siRNA of gp91phox (the major subunit of NOX2
expressed in brain) in human PINK1 KD neuroblastoma cells
(n = 2 clones). Reduction of NOX2 expression was confirmed
by qRT-PCR (data not shown). Physiologically, application of
the main activator of NOX, PMA, further confirmed the pres-
ence/absence of the enzyme in ROS production. In NOX2-siRNA
PINK1 KD cells, the basal ROS production was significantly
reduced compared to PINK1 KD cells treated with scrambled
siRNA (from 315.6% ± 25.7% to 126.7% ± 9.4% of control,
n = 96 control neuroblastoma cells; n = 92 for PINK1 KD;
n = 127 for NOX2-siRNA PINK1 KD; Figure 6F). Thus, in the
absence of NOX2, PINK1 KD does not result in cROS overpro-
duction.
Mitochondrial ROS. The rate of basal mitochondrial ROS
(mROS) production was also significantly higher in PINK1 KD/
KO cells than in controls (210.2% ± 18.1% of control, n = 165
for KO neurons; p < 0.001; Figures 6C and 6D). Inhibition of
complex I by rotenone (5 mM) stimulated ROS production in
control cells but not significantly in PINK1 KD/KO cells (in control
neurons the rate of ROS production increased to 253.8% ±
19.9%, n = 187; p < 0.001; in KO neurons the rate rose from
210.2% ± 18.1% to 242.4 ± 14.9%, n = 165). This suggests
that mROS production in the PINK1 KD/KO cells is already
activated at basal levels by impairment of complex I.
Consequences of Increased ROS. PINK1 KO cortical neurons
were incubated with the ROS scavenger MnTBAP (10 mM). The
resulting reduction of ROS generation in PINK1 KO cells signifi-
cantly increased the rate of glucose uptake from 41.7% ± 3.9%
to 79.1% ± 5.8% of controls, n = 56; p < 0.05 (Figure 6E). Prein-
cubation with an inhibitor of NOX, DPI (0.5 mM), reduced the
production of cROS and also restored glucose transport to
control values (from 41.7% ± 3.9% to 104.8% ± 9.8%, n = 68;
Figure 6E). Furthermore, NOX2-siRNA in PINK1 KD cells also
restored glucose uptake to control values (from 48.6% ± 3.9%
to 95.6% ± 7.4% of controls, n = 143 for control; n = 131 for
PINK1 KD; n = 165 for PINK1 KD with NOX2siRNA; p < 0.001;
Figure 6G). However, modulation of ROS production had no
effect on the Ca2-induced Dcm depolarization (data not shown).
Overall, these results suggest that the major consequence of
PINK1 deficiency is an increase in [Ca2+]m, and a reduced Ca
2+
capacity, secondary to dysfunction of the Na+/Ca2+ exchanger.
Secondary effects of raised [Ca2+]c, such as activation of NADPH
oxidase, cause increased ROS production, which results in
calcium concentration to which mitochondria are exposed. Control human
mitochondria (G) demonstrated a much higher Ca2+ capacity compared to
PINK1 KD mitochondria (H). Control neurons are able to partially maintain
the Dcm, until the collapse of the fluo-4 fluorescence. WT mouse neurons (I)
also exhibited a higher Ca2+ capacity than PINK1 KO neurons (J). Note that
human control neurons showed a significantly higher calcium capacity
compared to mouse WT neurons.olecular Cell 33, 627–638, March 13, 2009 ª2009 Elsevier Inc. 633
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PINK1 Deficiency and Mitochondrial FunctionFigure 6. Increase in Mitochondrial and Cytosolic ROS Production
in PINK1 KD/KO Neurons
(A and B) (A) WT cortical neurons (Ai) demonstrated an increase in HEt fluores-
cence, and thus cROS production, in response to 50 mM KCl, which was
prevented by inhibition of NOX using DPI. PINK1 KO neurons (Aii) exhibited
a higher basal level of ROS production than WT neurons. The basal ROS
production and the response to KCl were blocked by inhibition of NOX in
PINK1 KO neurons. (B) Histogram shows percentage values of rate of HEt fluo-
rescence compared to 100% for WT neurons.
(C and D) PINK1 KO neurons displayed a higher basal rate of increase in
MitoSOX fluorescence, demonstrating a higher basal production of mROS
compared to controls. Inhibition of complex 1 with rotenone induced a signifi-
cant increase in ROS production in control neurons but only a small increase in
ROS production in PINK1 KO neurons. (D) Histogram demonstrates
percentage values of rate of MitoSOX fluorescence compared to 100% for
WT neurons.
(E) The rate of 2-NBDG fluorescence was lower in PINK1 KO neurons
compared to WT neurons, reflecting lower glucose uptake. Incubation of
PINK1 KO neurons with ROS scavenger MnTBAP increased the glucose
uptake. Incubation of PINK1 KO neurons with the NOX inhibitor DPI restored
glucose uptake to control levels.
(F) The increase in the rate of HEt fluorescence in PINK1 KD cells was
abolished by treatment of PINK1 KD cells with NOX-2 siRNA.
(G) The reduced rate of 2-NBDG fluorescence in PINK1 KD cells was rescued
by treatment of PINK1 KD cells with NOX-2 siRNA.
Error bars represent mean ± SEM.634 Molecular Cell 33, 627–638, March 13, 2009 ª2009 Elsevier Incimpairment of glucose uptake, a reduction in substrate avail-
ability, a lower level of respiration, and a lower basal Dcm. These
processes and their consequences are outlined in Figure 7.
DISCUSSION
The first and most robust animal models of Parkinson’s disease
have been toxin-based models using the complex 1 inhibitors
rotenone and MPTP (Betarbet et al., 2000; Forno et al., 1986).
Such models recapitulated selective dopaminergic neuronal
loss, a-synuclein-positive aggregates, and the clinical features
of parkinsonism. However, the use of complex 1 toxins
precludes the study of the natural pathophysiological events
within mitochondria prior to neuronal death. Genetic models of
the autosomal recessive PD have been less successful at repro-
ducing the clinicopathological features of PD in vivo mammalian
models (Kitada et al., 2007). However, in vitro models of PINK1
deficiency have produced phenotypes consistent with PD,
namely age-related dopaminergic neuronal loss with mitochon-
drial dysfunction and oxidative stress (Wood-Kaczmar et al.,
2008). Moreover, the in vitro models enable the physiologic
events occurring within neurons, directly due to a mutation
causing PD, to be characterized.
A reduction of complex 1 activity by 30% has been described
in brain, muscle, and platelets of patients with sporadic PD
(Schapira et al., 1990). Here, we demonstrate that the absence
of PINK1 is associated with inhibition of respiration, with
concomitant reduced oxygen consumption and an altered redox
state. The lowered activity of the respiratory complexes is
insufficient to maintain the Dcm, and hence results in a decrease
in Dcm. As a result, the mitochondria switch from the production
of ATP to the consumption of ATP by the F1F0-ATPase in order to
maintain their Dcm (Campanella et al., 2008). Interestingly, this
phenomenon could be reversed by the provision of additional
respiratory chain substrates: the increase in respiration in the
presence of additional pyruvate resulted in a concomitant switch
in the mechanism ofDcm maintenance from hydrolysis of ATP to
production of ATP. The ability to reverse the respiratory chain
inhibition and repolarize the Dcm has not been previously
demonstrated in PD. These data strongly suggest that the
respiratory complexes in PINK1 deficiency are intact and that
their functional inhibition is in fact secondary to reduced
substrate supply. In keeping with other reports in the literature
(Scheele et al., 2007), we found that PINK1 loss of function
was associated with reduction in glucose uptake at the plasma-
lemmal membrane in human and mouse neurons. Thus, we
conclude that reduced substrate delivery causes the impairment
of respiration and reduced Dcm in cells that lack PINK1.
One of the major functions of the mitochondria is the mainte-
nance of calcium homeostasis within the cell. Abnormal calcium
homeostasis has been implicated in a range of diseases such as
Alzheimer’s disease (Abramov et al., 2003, 2004), Huntington’s
disease, amyotrophic lateral sclerosis, and stroke (Mattson,
2007). In PD, one important observation is that adult dopami-
nergic neurons are uniquely dependent on calcium channels
(rather than sodium channels) to maintain autonomous pacing
activity. As a result these neurons are exposed to frequent large
influxes of cytosolic calcium, which must be buffered by the.
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in particular an inability to handle these calcium loads may
render dopaminergic neurons particularly vulnerable to injury.
Furthermore, it has been reported that SN and VTA neurons
that express higher levels of calcium-binding proteins such as
calbindin are spared in both sporadic PD and MPTP toxicity
(Damier et al., 1999; Liang et al., 1996). However, the nature of
calcium dysregulation and its contribution to neuronal death is
largely uncharacterized in PD. We report that human and mouse
neurons lacking PINK1 have a higher basal [Ca2+]m than control
neurons. Furthermore, stimuli that induce a rise in cytosolic
calcium cause mitochondrial calcium overload with greatly
impaired recovery. As a consequence of this, the mitochondrial
calcium uptake capacity is dramatically reduced in the absence
of PINK1. Thus, repetitive rises in cytosolic calcium result in
mitochondrial calcium overload, leading to premature opening
of the PTP, profound mitochondrial depolarization, and ulti-
mately cell death (Crompton, 1999; Nicholls and Budd, 2000).
In addition, the opening of the PTP by calcium is modulated by
factors such as lowered basalDcm and raised mROS production
(described below), which also occur in PINK1 deficiency.
Accumulation of calcium within the mitochondria matrix
depends on both calcium uptake into the mitochondria through
an electrogenic uniporter, as well as extrusion of calcium from
the mitochondria through Na+/Ca2+ and H+/Ca2+ antiporters
(Szabadkai et al., 2006). Our data suggest that the cause of
mitochondrial calcium accumulation in PINK1 deficiency is
a direct impairment of calcium efflux from the mitochondria
secondary to dysfunction of the Na+/Ca2+ exchanger. The
reasons for this are (1) following an increase in [Ca2+]m there
was no mitochondrial efflux of Ca2+ and concomitant influx of
Na+ (which would normally enable recovery of [Ca2+]m), (2) appli-
cation of external Na+ was able to activate the Na+/Ca2+
exchanger in control neurons but not in PINK1 KD neurons,
and (3) there was no apparent abnormality of calcium influx in
PINK1 KD/KO cells, To date, the existence of the calcium
uniporter and antiporters has been established only functionally.
Figure 7. Schematic Diagram Illustrating the Effects of PINK1 within
the Mitochondria and CytosolMThe Na+/Ca2+ antiporter was first recognized in heart and brain
mitochondria (Carafoli et al., 1974; Crompton et al., 1977,
1978). Although one putative candidate was reported to be iso-
lated from beef heart mitochondria (Li et al., 1992), the proteins
that truly account for the activity of these transporters have not
yet been identified and confirmed. We have shown physiologi-
cally that PINK1 regulates the Na+/Ca2+exchange mechanism
in mitochondria, and that this is fundamental to the role of
PINK1 in cell physiology. We are unable to prove biochemically
that the Na+/Ca2+exchanger is a direct substrate or interactor
of PINK1 because the molecular identity of this protein remains
unclear. In order to fully clarify the relationship between PINK1
and Na+/Ca2+ exchange, it is necessary to first identify this
protein, which is the subject of ongoing research.
One interesting observation in these experiments was the
significant difference in the mitochondrial calcium capacity of
mouse compared to human neurons. Control mouse neuronal
mitochondria depolarized at much lower calcium concentrations
than control human neurons. Control mouse neurons did not
accumulate mitochondrial calcium in the same way as normal
human neurons due to immediate opening of the PTP.
Oxidative stress has long been implicated in sporadic PD:
there is evidence of elevated levels of lipid peroxidation markers
(4-hydroxynonenal and malondialdehyde) and protein nitration in
the substantia nigra and in Lewy bodies of patients with PD
(Andersen, 2004). However, it is less clear whether the oxidative
stress is causal in PD or a consequence of dysfunctional
neurons. At a cellular level, overproduction of ROS would theo-
retically be able to inhibit the mitochondrial Na+/Ca2+ exchanger,
causing mitochondrial calcium overload, as well as inhibiting the
plasmalemmal glucose transporter and reducing respiration
(Jornot et al., 1999). In our models, we demonstrate that in the
absence of PINK1, there was a significant increase in ROS
production from two separate sources. There was an increase
in mROS that may be secondary to the increase in mitochondrial
calcium, as well as the impairment of respiration. Alternatively, it
is recognized that PTP opening per se results in an increase in
ROS production through a conformational change in complex I
(Batandier et al., 2004). In addition, there was overproduction
of cROS, in the form of superoxide by NOX. Increased activity
of NOX has been reported to be responsible for the oxidative
stress seen in other neurodegenerative diseases and is a major
source of ROS production in MPTP-induced cell toxicity
(Anantharam et al., 2007). As calcium is known to increase the
activation of NOX-2 (Abramov et al., 2005), we postulate that
cytosolic calcium may result in an increase in cROS production.
Manipulation of ROS production using inhibitors of NOX, NOX-2
(gp91phox) siRNA, and ROS scavengers enabled us to distinguish
the primary abnormalities from the secondary consequences of
ROS production in PINK1 KD/KO neurons. Reduction of ROS
production was able to reverse the impaired glucose uptake in
PINK1-deficient cells, and thus oxidative stress plays an im-
portant role in causing the impaired respiration seen in PINK1
KD/KO. Provision of substrates was also able to overcome the
impaired respiration and mitochondrial depolarization. However
neither reduction of ROS nor substrate provision was able to
affect mitochondrial calcium overload or calcium-induced mito-
chondrial depolarization in PINK1 KD/KO cells.olecular Cell 33, 627–638, March 13, 2009 ª2009 Elsevier Inc. 635
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physiology that occurs due to PINK1 loss of function and have
attempted to define mechanisms by which PINK1 deficiency
renders neurons vulnerable. Within mitochondria there is consid-
erable crosstalk between the bioenergetic function and calcium
homeostasis. Our data suggest that as a result of PINK1 defi-
ciency there is primarily an impairment of mitochondrial calcium
efflux resulting in mitochondrial calcium overload. This induces
a rise in ROS that may further impair calcium efflux and also
inhibit glucose uptake, resulting in reduced substrate delivery
and impaired respiration. Ultimately, the synergistic action of
increased mROS and mitochondrial calcium overload induces
opening of the PTP. Opening of the PTP, occurring either as an
early event (calcium-induced) or as a late event, has several
consequences that exacerbate the mitochondrial pathophysi-
ology and promote cell death: (1) PTP opening will further
increase ROS production in the mitochondria, (2) PTP opening
will result in reduced rate of maximal respiration through pyridine
nucleotide depletion (Di Lisa et al., 2001), and (3) PTP opening
will cause cytochrome c release and neuronal apoptosis.
Neurons of the substantia nigra, where there is increased
oxidative stress and large calcium influxes, will be particularly
susceptible to mitochondrial apoptosis via these mechanisms.
EXPERIMENTAL PROCEDURES
Cell Models
The generation, characterization, and maintenance of the neuroblastoma,
human neuron, and mouse neuronal cultures are described briefly in the
Supplemental Experimental Procedures and have been published elsewhere
(Wood-Kaczmar et al., 2008).
Loading of Cells
For measurements of [Ca2+]c and [Ca
2+]m, cells were loaded for 30 min at room
temperature with 5 mM of either fura-2 AM or fluo-4 AM in combination with
5 mM of either X-Rhod-1 AM or Rhod-5n, and 0.005% pluronic acid in
a HEPES-buffered salt solution (HBSS) composed of 156 mM NaCl, 3 mM
KCl, 2 mM MgSO4, 1.25 mM KH2PO4, 2 mM CaCl2, 10 mM glucose, and
10 mM HEPES (pH adjusted to 7.35 with NaOH). For flash photolysis experi-
ments, caged Ca2+, 10 mM o-nitrophenyl EGTA, AM (NP-EGTA, AM) was
loaded at the same time as the other indicators, and Ca2+-free medium
containing 0.5 mM EGTA was used. For experiments using permeabilized
cells, neurons were exposed to 20 mM digitonin in a ‘‘pseudo-intracellular’’
solution consisting of 135 mM KCl, 10 mM NaCl, 20 mM HEPES, 5 mM pyru-
vate, 5 mM malate, 0.5 mM KH2PO4, 1 mM MgCl2, 5 mM EGTA, and 1.86 mM
CaCl2 (to yield a free [Ca
2+] of 100 nM).
For measurements of Dcm, cells were loaded with 25 nM tetramethylrod-
amine methylester (TMRM) for 30 min at room temperature, and the dye was
present during the experiment. TMRM is used in the redistribution mode to
assess Dcm, and therefore a reduction in TMRM fluorescence represents
Dcm depolarization. Alternatively, Rh123 (26 mM, equivalent to 10 mg ml1;
Molecular Probes) was added to cells during the last 15 min and washed prior
to the experiment. Under these loading conditions, Rh123 is nontoxic and
gives a reliable and reproducible measure of Dcm through the ‘‘dequench’’
of mitochondrial fluorescence, and thus an increase in the Rh123 signal
reflects mitochondrial depolarization.
For measurement of mROS production, cells were preincubated with Mito-
SOX (5 mM, Molecular Probes, Eugene, OR) for 10 min at room temperature.
For measurement of cROS production, dihydroethidium (2 mM) was present
in the solution during the experiment. No preincubation (‘‘loading’’) was used
for dihydroethidium to limit the intracellular accumulation of oxidized products.
For glucose uptake experiments, the uptake of the fluorescent glucose
homolog 2-NBDG (Invitrogen) was measured by the addition of 40 nM636 Molecular Cell 33, 627–638, March 13, 2009 ª2009 Elsevier Inc2-NBDG in the presence of 0.25 mM glucose during a period of continuous
imaging.
Fluorescence Measurements
Fluorescence measurements were obtained on an epifluorescence inverted
microscope equipped with a 320 fluorite objective. [Ca2+]i and DJm were
monitored in single cells using excitation light provided by a Xenon arc lamp,
the beam passing sequentially through 10 nm band pass filters centered at
340, 380, and 490 nm housed in computer-controlled filter wheel (Cairn
Research, Kent, UK). Emitted fluorescence light was reflected through
a 515 nm long-pass filter to a cooled CCD camera (Hamamatsu, Orca ER)
and digitized to 12 bit resolution (Digital Pixel Ltd, UK). All imaging data were
collected and analyzed using software from Andor (Belfast, UK). Wherever
possible, we have normalized the signals between resting level (set to 0) and
a maximal signal generated in response to the uncoupler FCCP (1 mM; set to
100%).
Confocal images were obtained using a Zeiss 510 uv-vis CLSM equipped
with a META detection system and a 403 oil immersion objective. The
488 nm Argon laser line was used to excite fluo-4 fluorescence, which was
measured using a band-pass filter from 505 to 550 nm. Illumination intensity
was kept to a minimum (at 0.1%–0.2% of laser output) to avoid phototoxicity,
and the pinhole was set to give an optical slice of 2 mm. TMRM was excited
using the 543 nm laser line and fluorescence measured using a 560 nm long-
pass filter. For HEt, MitoSOX, X-Rhod, or Rhod-5n measurements the 543 nm
laser line and 560 nm long-pass filter were used. NADH autofluorescence was
excited at 351 and measured at 375–470 nm. 2-NDBG was excited at 458 nm,
and fluorescence was measured at 520 nm. All data presented were obtained
from at least five coverslips and two to three different cell preparations.
Oxygen Respiratory Activity
To measure respiration rate in intact cells, approximately 1 3 107cells were
suspended in respiration medium (HBSS) with 10 mM D-glucose in a Clark-
type oxygen electrode thermostatically maintained at 37C. The oxygen
electrode was calibrated with air-saturated water, assuming 406 nmol O
atoms/ml at 37C. Oxygen consumption was measured over 10 min with
addition of oligomycin (final concentration 2 mg/ml) and 0.5 mM FCCP. All
data were obtained using a MacLab system with Chart recording software.
Statistical Analysis
Data were generated from a minimum of three independent experiments,
using a minimum of 20 cells per experiment and replication in two to three
different clones for PINK1 KD. Statistical analysis and exponential curve fitting
were performed using Origin 7 (Microcal Software Inc., Northampton, MA)
software. Data were analyzed by parametric Student’s t tests and significance
expressed: *p < 0.05, **p < 0.005. For all graphs, error bars represent mean ±
SEM.
SUPPLEMENTAL DATA
The Supplemental Data include Supplemental Experimental Procedures and
two figures and can be found with this article online at http://www.cell.com/
molecular-cell/supplemental/S1097-2765(09)00129-4.
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